On May 21, 2021, Moderna announced that the Ministry of Food and Drug Safety of South Korea (MFDS) had approved the Companyﾒs application for Conditional Marketing Authorization for its mRNA vaccine against COVID-19. GC Pharma in South Korea is the Companyﾒs marketing authorization holder and distributor of Modernaﾒs COVID-19 vaccine for South Korea.